Sylvamo (SLVM) Tops Q2 EPS by 5c

Sylvamo (NYSE: SLVM) reported Q2 EPS of $1.14, $0.05 better than the analyst estimate of $1.09. Revenue for the quarter came in at $919 million versus the consensus estimate of $950.84 million.

For earnings history and earnings-related data on Sylvamo (SLVM) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Vertex to acquire Crinetics Pharmaceuticals for $10 billion
• AbbVie updates 2026 EPS guidance after $291M IPR&D charge